Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sustiva 100mg capsules
0503010D0BBABAB
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 200mg capsules
0503010D0BBAAAA
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 30mg/ml oral solution
0503010D0BBAEAE
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 50mg capsules
0503010D0BBACAC
|
Sustiva | Efavirenz | Infections | No data available |
|
Sustiva 600mg tablets
0503010D0BBADAD
|
Sustiva | Efavirenz | Infections | No data available |
|
Synagis 100mg inj vials
0503050A0BBAAAA
|
Synagis | Palivizumab | Infections | No data available |
|
Synagis 100mg/1ml solution for injection vials
0503050A0BBADAD
|
Synagis | Palivizumab | Infections | No data available |
|
Synagis 50mg inj vials
0503050A0BBABAB
|
Synagis | Palivizumab | Infections | No data available |
|
Synagis 50mg/0.5ml solution for injection vials
0503050A0BBACAC
|
Synagis | Palivizumab | Infections | No data available |
|
Synercid powder for solution for infusion vials
0501070V0BBAAAA
|
Synercid | Quinupristin/dalfopristin | Infections | No data available |
|
Talidex 25mg tablets
0501100J0BCAAAJ
|
Talidex | Thalidomide (Antileprotic) | Infections | No data available |
|
Tamiflu 12mg/ml oral suspension
0503040B0BBABAB
|
Tamiflu | Oseltamivir phosphate | Infections | No data available |
|
Tamiflu 45mg capsules
0503040B0BBADAD
|
Tamiflu | Oseltamivir phosphate | Infections | No data available |
|
Targocid 200mg inj vials
0501070T0BBABAB
|
Targocid | Teicoplanin | Infections | No data available |
|
Targocid 400mg inj vials
0501070T0BBAAAA
|
Targocid | Teicoplanin | Infections | No data available |
|
Tarivid 200mg tablets
0501120P0BBAAAA
|
Tarivid | Ofloxacin | Infections | No data available |
|
Tarivid 200mg/100ml solution for infusion bottles
0501120P0BBADAC
|
Tarivid | Ofloxacin | Infections | No data available |
|
Tarivid 400mg tablets
0501120P0BBACAB
|
Tarivid | Ofloxacin | Infections | No data available |
|
Taurolidine 2% nebuliser liquid
0501070AAAAAAAA
|
Taurolidine | Taurolidine | Infections | No data available |
|
Taurolidine intraperitoneal solution bottles
0501070AAAAABAB
|
Taurolidine | Taurolidine | Infections | No data available |
|
Taurolin 100mg/5ml intraperitoneal solution bottles
0501070AABBAAAB
|
Taurolin | Taurolidine | Infections | No data available |
|
Tavanic 250mg tablets
0501120X0BBABAB
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tavanic 500mg tablets
0501120X0BBAAAA
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tavanic 500mg/100ml solution for infusion vials
0501120X0BBACAC
|
Tavanic | Levofloxacin | Infections | No data available |
|
Tazocin 2g/0.25g powder for solution for infusion vials
0501014S0BBAAAA
|
Tazocin | Piperacillin sodium/tazobactam sodium | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.